Tanabe Indonesia

PT Tanabe Indonesia is a leading pharmaceutical manufacturer and distributor based in Indonesia, operating as a subsidiary of the Japanese Mitsubishi Tanabe Pharma Corporation. Founded in 1970, the company has established a strong presence in the Southeast Asian market through the production of high-quality ethical medicines. Its core therapeutic focus areas include cardiovascular health, gastroenterology, nephrology, and metabolic disorders. The company operates a sophisticated, GMP-certified manufacturing facility in Bandung that produces a variety of dosage forms, including tablets and injections, for both local and export markets. Key products in its portfolio include Herbesser for hypertension and Tanatril for ACE inhibition, reflecting the company's commitment to chronic disease management. By integrating Japanese pharmaceutical innovation with local manufacturing excellence, Tanabe Indonesia continues to be a critical player in the Indonesian healthcare landscape.